The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-γ inducibility of TAP1 and LMP2

Oncogene

Volumn 25, Issue 29, 2006, Pages 4016-4026

  Hayashi, T ^a,c   Kobayashi, Y ^b   Kohsaka, S ^a   Sano, K ^b  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IFN ; JAK1; Leiomyosarcoma; LMP2; Uterus

Indexed keywords

ADENOSINE TRIPHOSPHATE; GAMMA INTERFERON; JANUS KINASE 1; PROTEIN; PROTEIN LMP2; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE MUTATION; HUMAN; HUMAN CELL; LEIOMYOSARCOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION; UTERUS SARCOMA;

ADENOSINE TRIPHOSPHATE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; CYSTEINE ENDOPEPTIDASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MHC CLASS I; HELA CELLS; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; JANUS KINASE 1; LEIOMYOMA; MICE; MICE, KNOCKOUT; POINT MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; SARCOMA; SIGNAL TRANSDUCTION; TUMOR ESCAPE; UTERINE NEOPLASMS;

EID: 33745793005     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209434     Document Type: Article

References (34)

1. Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F et al. (2004). Int J Cancer 109: 265-273.
2. Belich MP, Glynne RJ, Senger G, Sheer D, Trowsdale J. (1994). Curr Biol 4: 769-776.
3. Brucet M, Marques L, Sebastian C, Lloberas J, Celada A. (2004). Genes Immun 5: 26-35.
4. Cabrera CM, Jimenez P, Cabrera T, Esparza C, Ruiz-Cabello F, Garrido F. (2003). Tissue Antigens 61: 211-219.
5. Chatterjee-Kishore M, Wright KL, Ting JP, Stark GR. (2000). EMBO J 19: 4111-4122.
6. Dovhey SE, Ghosh NS, Wright KL. (2000). Cancer Res 60: 5789-5796.
7. Driscoll J, Brown MG, Finley D, Schreiber RD. (1993). Nature 365: 262-264.
8. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. (2002). Nat Immunol 3: 991-998.
9. Gaczynska M, Rock KL, Goldberg AL. (1993). Nature 365: 264-267.
10. Garrido F, Ruiz-Cabello F, Cabrera T, Cozar JM, Pedrinaci S, Tallada M et al. (1997). Immunol Today 18: 89-95.
11. Groettrup M, Standera S, Stohwasser R, Kloetzel PM. (1997). Proc Natl Acad Sci USA 94: 8970-8975.
12. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M et al. (1993). Science 259: 971-974.
13. Hayashi T, Faustman DL. (2002). Cancer Res 62: 24-27.
14. Hayashi T, Sekine T, Okamoto T. (1993). J Biol Chem 268: 26790-26795.
15. Hsu SM, Raine L, Fanger H. (1981). J Histochem Cytochem 29: 577-580.
16. Ihle JN. (2001). Curr Opin Cell Biol 13: 211-217.
17. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ et al. (1998). Proc Natl Acad Sci USA 95: 7556-7561.
18. Leiser AL, Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi DS et al. (2005). Gynecol Oncol (Epub ahead of print).
19. Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P et al. (2004). Cancer 101: 1455-1462.
20. Maniatis T. (1999). Genes Dev 13: 505-510.
21. Miyagi T, Tatsumi T, Takehara T, Kanto T, Kuzushita N, Sugimoto Y et al. (2003). J Gastroenterol Hepatol 18: 32-40.
22. Momburg F, Neefjes JJ, Hammerling GJ. (1994a). Curr Opin Immunol 6: 32-37.
23. Momburg F, Roelse J, Howard JC, Butcher GW, Hammerling GJ, Neefjes JJ. (1994b). Nature 367: 648-651.
24. O'Shea JJ, Gadina M, Schreiber RD. (2002). Cell 109: 121-131.
25. Platanias LC. (2005). Nat Rev Immunol 5: 375-386.
26. Ramana CV, Gil MP, Schreiber RD, Stark GR. (2002). Trends Immunol 23: 96-101.
27. Raspollini MR, Pinzani P, Simi L, Amunni G, Villanucci A, Paglierani M et al. (2005). Gynecol Oncol 98: 334-335.
28. Seliger B, Maeurer MJ, Ferrone S. (2000). Immunol Today 21: 455-464.
29. Sexl V, Kovacic B, Piekorz R, Moriggl R, Stoiber D, Hoffmeyer A et al. (2003). Blood 101: 4937-4943.
30. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ et al. (2001). Nature 410: 1107-1111.
31. Singal DP, Ye M, Ni J, Snider DP. (1996). Immunol Lett 50: 149-154.
32. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL et al. (1994). Immunity 1: 533-541.
33. White LC, Wright KL, Felix NJ, Ruffner H, Reis LF, Pine R et al. (1996). Immunity 5: 365-376.
34. Wright KL, White LC, Kelly A, Beck S, Trowsdale J, Ting JP. (1995). J Exp Med 181: 1459-1471.